Evidence map›Paper›PMID 39686781›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Community-Based Tuberculosis Isolation Decisions Require Individualization Based on Effectiveness and Duration of Treatment, Community Risks, and Patient Harms.

Maunank Shah, Ruvandhi Nathavitharana, Joseph Burzynski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Maunank ShahDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-0979-2388
Ruvandhi NathavitharanaDivision of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-3544-5021
Joseph BurzynskiNew York City Department of Health and Mental Hygiene, New York, New York, USA.ORCID 0000-0002-7109-7669

Funding

THWART-TB : Testing Health Workers At Risk to advance our understanding of TB infectionDP2AI176896 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Ruvandhi Nathavitharana · 2023 to 2026
$1.6M
Optimizing Diagnostic Strategies for TB Transmission Control in Health-Care FacilitiesK23AI132648 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NATHAVITHARANA, RUVANDHI · 2018 to 2022
$945k
National Institute of Allergy and Infectious Diseases, National Institutes of Health DP2-AI176896National Institute of Allergy and Infectious Diseases, National Institutes of Health K23 AI132648-05National Institute of Allergy and Infectious Diseases, National Institutes of Health P30AI18436NIAID NIH HHS DP2 AI176896NIAID NIH HHS K23 AI132648
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39686781
PMCPMC12314489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.